Why The Ensign Group, Inc.’s (ENSG) Stock Is Up 8.51%
As of Wednesday, October 28, The Ensign Group, Inc.’s ENSG share price has surged by 8.51%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Stock Evaluator: The Ensign Group, Inc. (ENSG)
The Ensign Group, Inc. ENSG
$181.52
-4.80
-2.58%
October 30, 2026 4:00:00 PM
EST
Volume: 411,630
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The Skilled Services segment provides short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management; and standard services, such as room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. The Standard Bearer segment leases post-acute care properties to healthcare operators. In addition, the company operates senior living units; and provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. The company operates healthcare facilities in Alabama, Alaska, Arizona, Colorado, Idaho, Iowa, Kansas, Oregon, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Commentary & Analysis
What You Need to Know About The Ensign Group, Inc.'s Q4 Earnings
The Ensign Group, Inc.'s fiscal Q4 earnings report was released on Tuesday, October 27. Let's dive in to see if (ENSG) missed or beat analyst's expectations.Rosalio Madrigal
Which Is a Better Investment, The Ensign Group, Inc. or NeoGenomics, Inc. Stock?
Learn more about whether The Ensign Group, Inc. or NeoGenomics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Michael Rose
Why The Ensign Group, Inc.’s (ENSG) Stock Is Up 5.01%
As of Monday, July 27, The Ensign Group, Inc.’s ENSG share price has surged by 5.01%, which has investors questioning if this is right time to sell.Jenna Brashear
What You Need to Know About The Ensign Group, Inc.'s Q3 Earnings
The Ensign Group, Inc.'s fiscal Q3 earnings report was released on Monday, July 27. Let's dive in to see if (ENSG) missed or beat analyst's expectations.Jenna Brashear
Financial Summary
| Share Statistics | ENSG | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $10,500.5 | $1,847.0 | 79% |
|
| Shares Out (Mil) | 59.3 | 81.4 | 52% |
|
| Institutional Ownership | 96.2% | 85.8% | 69% |
|
| Float (Mil) | 55.6 | 57.1 | 49% |
|
| Beta | 0.66 | 0.75 | 38% |
|
| Avg Daily Volume (000s) | 446 | 673 | 57% |
|
| Price Change (52-week) |
(0.7%) | 80.0% | 51% |
|
| Growth | ENSG | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 16.1% | 10.4% | 75% |
|
| Net Income (5yr) | 15.1% | (0.7%) | 64% |
|
| EPS (5yr) | 13.8% | 0.3% | 54 |
|
| Dividends (5yr) | 4.5% | 0.0% | 63% |
|
| Cash Flow (5yr) | (27.0%) | (17.4%) | 23% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 5 | 5 | 5 | |
| Current EPS | $2.146 | $7.933 | $8.705 | |
| Month Ago EPS | $2.065 | $7.794 | $8.553 | |
| # Rev Up | 0 | 2 | 3 | |
| # Rev Down | 1 | 0 | 0 | |
| Three Months Ago EPS | $2.065 | $7.794 | $8.553 | |
| Year/Year Chg | 21.9% | 35.8% | 63.9% | |
| Financials | ENSG | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $5,674 | $1,504 | 76% |
|
| Net Income (TTM) (Mil) | $399 | $31 | 76% |
|
| EPS (TTM) | $6.907 | $0.300 | 90% |
|
| Operating Cash Flow (TTM) (Mil) | $696 | $157 | 76% |
|
| Net Cash Flow (TTM) (Mil) | ($106) | $2 | 14% |
|
| Long-Term Debt (Q1) (Mil) | $2,163 | $394 | 75% |
|
| Enterprise Value (Q1) (Mil) | $12,550 | $2,345 | 77% |
|
| Valuation | ENSG | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.10 | 2.88 | 76% |
|
| P/E | 27.0 | 26.5 | 67% |
|
| Dividend Yield | 0.1% | 0.0% | 60% |
|
| PEG (5yr hist) | 2.0 | 1.0 | 68% |
|
| Ratios | ENSG | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 17.1% | 27.0% | 17% |
|
| Net Margin | 7.0% | 1.3% | 54% |
|
| ROA | 7.1% | 2.1% | 79% |
|
| ROE | 17.1% | 6.9% | 75% |
|
| Liabilities to Assets | 57.3% | 62.1% | 51% |
|
| F-Score | 7 | 5 | 82% |
|
Passing Stock Screens
As of 10/30/2026, from a list of 60 stock screening strategies,
FACTOR STRATEGY
P/E Relative Screen
Factors: Value, Earnings Estimates
A screen that looks at the relationship of a stock's price-earnings ratio to that of the industry and market.
| Performance Since Inception: | 13.6% |
| +/- S&P 500: | +6.2 |
